Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

[Plasminogen activator system and its clinical significance in patients with a malignant disease].

Halámková J, Kiss I, Tomásek J, Pavlovský Z, Cech Z, Tutek S, Hanáková L, Moulis M, Penka M.

Klin Onkol. 2011;24(6):418-23. Review. Czech.

PMID:
22257230
[PubMed - indexed for MEDLINE]
2.

[Significance of urokinase and its inhibitors in the invasiveness and metastasing of malignant tumors].

Halámková J, Kiss I, Tomášek J, Pavlovský Z, Tuček S, Penka M.

Vnitr Lek. 2012 Feb;58(2):129-34. Review. Czech.

PMID:
22463093
[PubMed - indexed for MEDLINE]
3.

Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients.

Halamkova J, Kiss I, Pavlovsky Z, Tomasek J, Jarkovsky J, Cech Z, Tucek S, Hanakova L, Moulis M, Zavrelova J, Man M, Benda P, Robek O, Kala Z, Penka M.

Neoplasma. 2011;58(5):377-85.

PMID:
21744990
[PubMed - indexed for MEDLINE]
4.

Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading.

Planus E, Barlovatz-Meimon G, Rogers RA, Bonavaud S, Ingber DE, Wang N.

J Cell Sci. 1997 May;110 ( Pt 9):1091-8.

PMID:
9175705
[PubMed - indexed for MEDLINE]
Free Article
5.

Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.

Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.

Scand J Gastroenterol. 2005 Jul;40(7):783-93.

PMID:
16109653
[PubMed - indexed for MEDLINE]
6.

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A.

Int J Oncol. 2009 Jan;34(1):15-23.

PMID:
19082473
[PubMed - indexed for MEDLINE]
7.

Fibrinolysis: the key to new pathogenetic mechanisms.

Zorio E, Gilabert-Estellés J, España F, Ramón LA, Cosín R, Estellés A.

Curr Med Chem. 2008;15(9):923-9. Review.

PMID:
18473800
[PubMed - indexed for MEDLINE]
8.

[The clinical prospects for the study of the plasminogen activation system in breast cancer].

Gershteĭn ES, Kushlinskiĭ NE.

Vestn Ross Akad Med Nauk. 1999;(8):58-61. Review. Russian.

PMID:
10487126
[PubMed - indexed for MEDLINE]
9.

Plasminogen activator system in oral squamous cell carcinoma.

Baker EA, Leaper DJ, Hayter JP, Dickenson AJ.

Br J Oral Maxillofac Surg. 2007 Dec;45(8):623-7. Epub 2007 Jun 21.

PMID:
17590247
[PubMed - indexed for MEDLINE]
10.

The role of the plasminogen system in bone resorption in vitro.

Daci E, Udagawa N, Martin TJ, Bouillon R, Carmeliet G.

J Bone Miner Res. 1999 Jun;14(6):946-52.

PMID:
10352103
[PubMed - indexed for MEDLINE]
11.

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.

Kjøller L, Kanse SM, Kirkegaard T, Rodenburg KW, Rønne E, Goodman SL, Preissner KT, Ossowski L, Andreasen PA.

Exp Cell Res. 1997 May 1;232(2):420-9.

PMID:
9168821
[PubMed - indexed for MEDLINE]
12.

Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.

Zhang LP, Takahara T, Yata Y, Furui K, Jin B, Kawada N, Watanabe A.

J Hepatol. 1999 Oct;31(4):703-11.

PMID:
10551395
[PubMed - indexed for MEDLINE]
13.

Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion.

Bonavaud S, Charrière-Bertrand C, Rey C, Leibovitch MP, Pedersen N, Frisdal E, Planus E, Blasi F, Gherardi R, Barlovatz-Meimon G.

J Cell Sci. 1997 May;110 ( Pt 9):1083-9.

PMID:
9175704
[PubMed - indexed for MEDLINE]
Free Article
14.

Analysis of expressions of components in the plasminogen activator system in high- and low-metastatic human lung cancer cells.

He C, He P, Liu LP, Zhu YS.

J Cancer Res Clin Oncol. 2001;127(3):180-6.

PMID:
11260863
[PubMed - indexed for MEDLINE]
15.

Regulation and interactions in the activation of cell-associated plasminogen.

Myöhänen H, Vaheri A.

Cell Mol Life Sci. 2004 Nov;61(22):2840-58. Review.

PMID:
15558213
[PubMed - indexed for MEDLINE]
16.

Regulation and role of urokinase plasminogen activator in vascular remodelling.

Tkachuk V, Stepanova V, Little PJ, Bobik A.

Clin Exp Pharmacol Physiol. 1996 Sep;23(9):759-65. Review.

PMID:
8911711
[PubMed - indexed for MEDLINE]
17.

Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.

Plesner T, Behrendt N, Ploug M.

Stem Cells. 1997;15(6):398-408. Review.

PMID:
9402652
[PubMed - indexed for MEDLINE]
Free Article
18.

Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways.

Schnaper HW, Barnathan ES, Mazar A, Maheshwari S, Ellis S, Cortez SL, Baricos WH, Kleinman HK.

J Cell Physiol. 1995 Oct;165(1):107-18.

PMID:
7559792
[PubMed - indexed for MEDLINE]
19.

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin.

Stefansson S, Lawrence DA.

Nature. 1996 Oct 3;383(6599):441-3.

PMID:
8837777
[PubMed - indexed for MEDLINE]
20.

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ.

J Cell Biol. 1996 Sep;134(6):1563-71.

PMID:
8830783
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk